chrisvoncsefalvay/vaers-outcomes huggingface dataset:
popping in her head like a pressure; Jaw flared up; sinusitis congestion; burning on top of head, sculp burning; Sensitive to day light really hypersensitive; vertigo; sever pain in neck; Injection site sore as usual; Lymph nodes under her arm swollen; fever; chills, freezing; nausea; fatigue; massive head ache; woke up some arthritic injuries; This spontaneous case was reported by a patient and describes the occurrence of HEAD DISCOMFORT (popping in her head like a pressure), JAW DISORDER (Jaw flared up), SINUSITIS (sinusitis congestion), BURNING SENSATION (burning on top of head, sculp burning) and PHOTOPHOBIA (Sensitive to day light really hypersensitive) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In September 2022, the patient experienced HEAD DISCOMFORT (popping in her head like a pressure), JAW DISORDER (Jaw flared up), SINUSITIS (sinusitis congestion), BURNING SENSATION (burning on top of head, sculp burning), PHOTOPHOBIA (Sensitive to day light really hypersensitive), VERTIGO (vertigo), NECK PAIN (sever pain in neck), VACCINATION SITE PAIN (Injection site sore as usual), LYMPHADENOPATHY (Lymph nodes under her arm swollen), PYREXIA (fever), CHILLS (chills, freezing), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (massive head ache) and ARTHRALGIA (woke up some arthritic injuries). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEAD DISCOMFORT (popping in her head like a pressure), JAW DISORDER (Jaw flared up), SINUSITIS (sinusitis congestion), BURNING SENSATION (burning on top of head, sculp burning), PHOTOPHOBIA (Sensitive to day light really hypersensitive), VERTIGO (vertigo), NECK PAIN (sever pain in neck), VACCINATION SITE PAIN (Injection site sore as usual), LYMPHADENOPATHY (Lymph nodes under her arm swollen), PYREXIA (fever), CHILLS (chills, freezing), NAUSEA (nausea), FATIGUE (fatigue), HEADACHE (massive head ache) and ARTHRALGIA (woke up some arthritic injuries) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative)
pt recv vax & exp sx of measles, mumps & rubella from which pt recovered p/2wk;pt had an adverse exp p/another vax (WAES98011184);
Intense vertigo, similar to what I experienced during my previous vestibular neuronitis events.  It's effectively inflammation pinching the vestibular nerve, which can only be helped by reducing the inflammation with steroids.  Treatment was prednisone for inflammation, zofran for nausea, meclizine for the vertigo symptoms, and zyrtec for reducing fluid build-up due to allergies.   Extreme symptoms lasted 4 days of absolutely no movement or even open eyes, then 2 weeks of limited ability to move, now able to function, but still feel slightly dizzy.  My doctors believe the vaccination contributed with general inflammation, which, combined with the allergies, triggered the event.
Yesterday -- one week after first injection --- I felt lethargic and generally unwell. I noticed my left arm itch in the morning but dismissed it and went about my day. I looked at my arm that evening and found I had a large red oval lesion had developed at injection site with some swelling, erythema,  mild itch, and mild discomfort. I took 50 mg benadryl last night one time before bed. The lesion looks about the same this morning maybe slightly larger and a little less brightly red but still erythemic.  I am waiting on results of a doctor telehealth E-visit I submitted to facility through their App last night to find out if I should get further treatment.
Shortness of breath chest pain, hot/ cold, head ache, sharp pain in stomach, dizziness, fatigue, fever, nasal congestion, muscle pain, Injection Site Pain, nausea
2 year old male patient received a dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) (batch number T343J, expiry date 25-JAN-2025) for prophylaxis.   On 02-AUG-2023, the patient received Kinrix. On 02-AUG-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 2 year old male patient received a dose). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 03-AUG-2023 The medical assistant reported that a patient received a dose of Kinrix with no symptoms reported. The vaccine was the fourth dose of each (per report to the 2nd line agent). A 2 year patient received Kinrix, which led to inappropriate age at vaccine administration. The reporter consented to follow up via email.
Right lip tingling shortly after vaccine. Within 24 hours symptoms of right facial herpes zoster,  shingles?. Started Valtrex 1000mg immediately.  Saw optometrist (who had seen cases of shingles after Pfizer COVID vaccine) and notified healthcare provider
After gettting the shots, at nighttime, patient complaint of hot/ burning, swollen, very sore, painful and red (but not itchy) left upper arm. In the afternoon of the next day when she came to the pharmacy to share with us, we took some photos to document it and to make sure the redness did not spread some more.
A healthcare professional reported the occurrence of injection site cellulitis in a 4 year old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On 5/12/03, the subject received her fifth injection of Infanrix (lot DTPA594A2). On the same date, she received injections of inactivated poliomyelitis and MMR. The subject developed early cellulitis at the site of Infanrix administration, within 24 to 48 hours post immunization, and was seen by the physician. Unspecified antibiotics and diphenhydramine hydrochloride were prescribed. The reporter considered the injection site cellulitis to be probably related to Infanrix administration.
Patient received J&J Janssen vaccine 4/8.  She reported nausea, abd pain, fevers, and fatigue since received vaccine.  On 4/13/2021 presented with worst headache of life, trouble speaking, and abnormal gait.   Exam showed L sided motor weakness and impaired sensation.    Initial CT normal, received tPA for presumed stroke.   Platelet count normal.  Currently admitted to critical care unit at Hospital.
11/13/12 Migraine lasting approx 9 hours after receiving flu vaccine using 2 step method. 11/14/12 Describes 4 asthma attacks through night requiring inhaler and rash around neck.
Child received KINRIX, HEP A #2, MMR #1, VARIVAX #2 and also flu vaccine. About five minutes later child c/o itching and developed hives and flushing. Immediately BENADRYL 25 mg PO given and child observed in clinic x 45 minutes. Symptoms improved.
SEVERE DEBILITATING VERTIGO; PERIPHERAL PARESTHESIA IN LOWER LEG AND HANDS; FLU SYMPTOMS; This spontaneous report received from a patient concerned a 32 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no known allergies and no medical history. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 043821A, batch number: 0438219, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the patient experienced flu symptoms. On 17-APR-2021, the patient experienced peripheral paresthesia in lower leg and hands. On 17-APR-2021, the patient experienced severe debilitating vertigo. Laboratory data (dates unspecified) included: Magnetic resonance imaging head (NR: not provided) Normal, and Magnetic resonance imaging neck (NR: not provided) Normal. The action taken with covid-19 vaccine was not applicable. The patient recovered from flu symptoms, had not recovered from peripheral paresthesia in lower leg and hands, and the outcome of severe debilitating vertigo was not reported. This report was non-serious.
This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL DISCOMFORT (Both had some tummy issues after receiving it) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7166B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Both had some tummy issues after receiving it). At the time of the report, ABDOMINAL DISCOMFORT (Both had some tummy issues after receiving it) outcome was unknown.            No concomitant medications were reported.  Patient and patient's mother received booster shot on Monday and both had some tummy issues after receiving it.  No treatment medications were reported.
HEARING LOSS; INFECTION IN BOTH EARS; This is a spontaneous report from a contactable consumer (patient). A 64-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8733 (reported as 7/21 ER8733)), via an unspecified route of administration, administered in left arm on 01Apr2021 17:00 (at 64-year-old, non-pregnant) as dose 2, single for COVID-19 immunization. The patient's medical history was none. No known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9261), via an unspecified route of administration, administered in left arm on 09Mar2021 10:00 AM (at 64-year-old) as dose 1, single for COVID-19 immunization. On 19Apr2021 at 13:00 the patient experienced infection in both ears, hearing loss. The events resulted doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events included antibiotics. The outcome of the events was not recovered. Since the vaccination, the patient had not been tested for COVID-19.
I had 3 days of severe migraine headache followed by 3 more days of headaches. at the same time entire body from head to toe aches. Joints felt inflamed and hard to use my body to perform ADL's. I felt like shit. If I had to rate my pain 1-10 I would say 40 (onset 9 hours post injection).
"Moderna COVID-19 Vaccine.   Vaccine on 2/25.  Took him to an urgent care on 3-7 because of swollen ankle, foot and lower leg. Had xray but nothing was broken. thought he had sprained ankle.  Given prednisone.  Ankle continued to be swollen for following days so we followed up with family dr. on 3-22  who sent him for ultrasound which showed an extensive blood clot - DVT.   Sent to emergency room.  Put on blood thinner shots for a week and sent to doctor on 3-24.  He did many blood tests.  He started eliquis on 3-30.  Saw doctor again on 4-13.  His blood tests had shown he has Factor 5--Leiden.  On May 11 we saw doctor again.  Remain on Eliquis.  Another ultrasound and more bloodtests show clot is chronic, but blood thinner is doing its job.  No active clotting.
o Patient received Moderna vaccine IM to left arm. Patient reports the area is red and itchy. Patient stated she does not have a history of allergies to medication or food. Vitals sign taken BP 154/76 P 72 o2 sat on room air 99% at 10:40 am. 10:55 am VS BP 143/73 P 72 o2 sat 98% on room air. Patient denies any SOB ,dizziness, chest pain or severe headache. Patient transferred via ambulation to clinic for further evaluation. o Patient transferred via ambulation to clinic for further evaluation. Patient will be evaluated for further treatment by staff.
Swollen right axillary lymph node (4.6cm) first noticed 5-6 days after vaccine. Still present 4 weeks after vaccine date.
severe fatigue, body pain; pt reports not being able to move easily and was close to going to hospital
This is a spontaneous report from a contactable nurse who reported 10 cases for different patients. This is the 6th of 10 cases. A patient of unspecified age ethnicity and gender received PREVNAR 13, via an unspecified route of administration, on an unspecified date, at 0.5 ml single, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced the injection hurt a lot on an unspecified date with outcome of unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2017083713 Same reporter/drug/event, different patient.
Initial information received on 04-Dec-2018 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves a female patient of unknown age who experienced Pain of skin, Burning sensation, vaccination site pain, Skin exfoliation, Feeling hot, Malaise and pain while she received vaccine FLUZONE QUADRIVALENT (Suspension for injection). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot U6260BA (expiry date: 30-Jun-2019) via unknown route and unknown site. On an unknown date, the patient started to feel sick, was achy, wasn't feeling good, skin felt like I was on fire, face was peeling, skin hurts if anything touched, it was reported that there was soreness at the injection site and that the burning was in her face and neck post vaccination with FLUZONE QUADRIVALENT. No lab test was reported. Final diagnosis was Pain of skin, Burning sensation, vaccination site pain, Skin exfoliation, Feeling hot, Malaise and pain. It was not reported if the patient received a corrective treatment. Outcome of the events was unknown for all the events. Documents held by sender: none.
Reddish rash at the vaccine site, small headaches, tired and a bit winded when I tried jogging. Overall - i?ll take it! Thankful to be vacc?d
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In approximately March 2016, the patient saw television advertisements related to ZOSTAVAX which induced her to ask her physician to prescribe her the ZOSTAVAX. On or about April 2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended. Instead, the patient contracted a persistent strain of shingles, or herpes zoster. On or about August 2016, the patient was treated by a physician and was diagnosed with shingles. The outcome of the events is unknown. As a direct and proximate result of the defective ZOSTAVAX, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Headache, Arthralgia, Fatigue Narrative:  Achy neck, back, and knees  Other Relevant History:
feeling pain at injection site; injection site is turned into black and blue in color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (feeling pain at injection site) and VACCINATION SITE DISCOLOURATION (injection site is turned into black and blue in color) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (feeling pain at injection site) and VACCINATION SITE DISCOLOURATION (injection site is turned into black and blue in color). At the time of the report, VACCINATION SITE PAIN (feeling pain at injection site) and VACCINATION SITE DISCOLOURATION (injection site is turned into black and blue in color) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
started w/fever of 104.7 On 4DEC97 lethargic, staring off into space;no evidence of sz fever  up to 105.5 @ 5AM 5DEC97;tepid bath x 1hr w/Ibuprofen down to 102.5;hx of high fever never any sx;swollen glands;
No additional AEs; vaccine administered after temperature excursions; This spontaneous report was received from an Other Health Professional and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 11-AUG-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot #X006983, expiration date: 07-MAR-2025, administered intramuscularly for prophylaxis (strength was not provided). On an unknown date before vaccination, the varicella virus vaccine live (oka/merck) (VARIVAX) was underwent a temperature excursion of 18.3 degree Fahrenheit (F) for 1 hour and 5 minutes (product storage error). No previous temperature excursion. No additional adverse events (AEs).
pt given Td on 18JUL94, area on lt deltoid, swollen 35mm, red & warm to touch; t98.6;
Diagnosed with COVID-19 on 02/27/2022. It started with head congestion, headache, sore throat, postnasal drainage, coughing, sneezing, burning sensation in my chest, fatigue, fever of 101. Fever lasted 3 days and the symptoms went on for 5 days then improved. Just my sinuses where not good, I ended up with a sinus infection right afterwards.  I still have lingering fatigue.
My first three doses were Pfizer and my 4th dose was Moderna. About two months after my last vaccination I woke up with a sore throat Sunday morning, 5/22. I had a feeling it was Covid because my daughter was visiting me and had tested positive, her and her sister had gone to a concert. I was negative on Sunday and Monday but tested positive on home test Tuesday morning. I felt like I had a cold, sore throat, and my voice started getting hoarse on Wednesday. Wednesday I woke up at 1 45 in the morning, I was having trouble breathing. I realized my inhaler wasn't working and I called my son to take me to take the ER. I had developed strider, beyond wheezing. They saw me right away, and got me into the ER. The wheezing had gotten a little better but they started an IV with a steroid. I asked the doctor to give me a MEDROL pack of prednisone because I knew it wouldn't go away without an additional steroid. They then gave me the MAB treatment. I arrived there at 4/5 30 that morning and I was able to go home at about 11 that day. I took the MEDROL pack for 7 days and that helped. I did have a telehealth appt on Tuesday with the local hospital and they told me they would send the PAXLOVID by Wednesday but that never happened, but I was okay with it because I had the MAB in the hospital. I did have severe fatigue almost a week afterwards. It starting getting better, my last bought of fatigue was last Tuesday afternoon 6/14. I do have a history of that happening with my allergies but this time with Covid was the worst it has ever felt, like my throat was closing up.
swollen lymph nodes; soreness up and down her neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes) and NECK PAIN (soreness up and down her neck) in a 23-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 016H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: INFLUENZA VACCINES on 22-Dec-2022 and PFIZER BIONTECH COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINES and PFIZER BIONTECH COVID-19 VACCINE.    On 22-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Dec-2022, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes) and NECK PAIN (soreness up and down her neck). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes) and NECK PAIN (soreness up and down her neck) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2023, Blood test: (Positive) doctor said she tested positive for mono.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Patient received vaccination of Pfizer 1st dose in April 2021, Pfizer 2nd dose in May 2021, Pfizer booster in December 2021. The patient reports she had bad swollen lymph nodes. She had soreness up and down her neck. It started 24 hours after the shot. It stuck around for a while, so patient got blood work. On 1Feb2023 she was tested positive for mono. She still having soreness and swollen lymph nodes now.   No treatment medication were reported.
EXTREMELY RAPID HEARTBEAT; MUSCLE ACHES; FLU; PAIN CONSISTENT; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced muscle aches. On MAR-2021, the subject experienced flu. On MAR-2021, the subject experienced pain consistent. On 10-MAR-2021, Laboratory data included: Heart rate (NR: not provided) 102 {beats}/min. On 10-MAR-2021 05:00, the subject experienced extremely rapid heartbeat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extremely rapid heartbeat on 10-MAR-2021 21:00, and the outcome of muscle aches, flu and pain consistent was not reported. This report was non-serious.